Skip to Main Content

Paper Details

RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.
Ann Surg Oncol
9
2022
BRAF, BRAF mutant, BRAF mutant tumors, HRAS, HRAS, KRAS, and NRAS mutant tumors, KRAS, NRAS, PTC, PTCs, Papillary Thyroid Cancers, Patient, Patients, RAS, RAS mutant tumors, RAS mutations, RET, RET Fusion, RET-rearranged tumors, Tumor, papillary thyroid cancer, patients, tumor, tumors
Author NameAffiliation
Shaham BegWeill Cornell Medical College
Juan Miguel MosqueraWeill Cornell Medical College
Juan Miguel MosqueraWeill Cornell Medical College
Olivier ElementoWeill Cornell Medical College
Olivier ElementoEnglander Institute for Precision Medicine, Weill Cornell Medical College
Olivier ElementoWeill Cornell Medical College
Olivier ElementoEnglander Institute for Precision Medicine, Weill Cornell Medical College
  • 1 - 7

Datasets

Release 1.2